Retatrutide vs Semaglutide
11 sources
Retatrutide, if you are carrying real weight and buying on the gray market. It is the stronger drug by a wide margin, with years of community mileage on it, and it runs a little hotter for the extra pull. Semaglutide wins when you can get it through a pharmacy, where a real prescription beats a gray-market vial, or when you want the longest safety record in the class more than you want maximum effect. Never run the two together.
How they differ
The difference is strength, and what the strength costs. Semaglutide, the drug in Ozempic and Wegovy, works one receptor, GLP-1: the stomach slows, food noise fades, and portions shrink without a fight. Retatrutide works that receptor plus two more, GIP and glucagon. The glucagon arm spends energy on top of cutting intake, which is why retatrutide out-cuts semaglutide on a heavy frame, and why you feel it more: a few extra beats a minute at rest, running warm at night, and more gut complaint near the top of its range. Semaglutide is the gentler ride.
Safer, on paper, is semaglutide: years of approved use and a finished cardiovascular outcomes trial. Retatrutide is not the risky one. It is the less documented one, and that is the trade. With a lot to lose and no prescription, retatrutide’s extra pull is the point and semaglutide is a step down on the same market. With a semaglutide script in hand, take it, and don’t swap it for a stronger vial of unknown origin. For lifters dieting down, neither is my first call; tirzepatide holds appetite firmly while you can still eat to train.
Day to day, the rhythm matches. Both sit in your blood for most of a week, so both are one pin on one day. The hollow look people call Ozempic face comes from how fast the weight leaves, not which drug took it, so the faster cut on retatrutide shows more of it; slower raises and high protein are the fix. If the semaglutide plus cagrilintide pairing brought you here, that is the combination in development as CagriSema. Cagrilintide works a separate hunger circuit, and its real use is bringing appetite control back when it fades, on either drug.
What the research shows
These two have never shared a trial. What follows is each one’s own program, read side by side:
The first two are different trials in different people, and retatrutide’s is smaller and shorter. Read with the meta-analysis, the shape holds: retatrutide cuts deeper and runs rougher, and semaglutide owns the hard-outcome proof.
How people run them
Run either one the same way: a sub-q pin once a week, with your appetite setting the dose. Begin at the bottom, stay put while hunger is quiet, and step up only when it genuinely comes back, about a month per step. A low dose that keeps working is a win, not a failure. The scales are different, though. A retatrutide milligram and a semaglutide milligram are not the same unit, so never carry a number from one to the other.
Switching from semaglutide to retatrutide, take the first retatrutide dose on the day your next semaglutide shot was due. No washout, no overlap. Start around 2 mg even if you were on the top semaglutide dose: your gut knows GLP-1 already, but the glucagon arm’s heat and heart-rate bump arrive fresh. Going the other way makes sense when semaglutide is the one a pharmacy will fill. Swap on the same day and start at 0.5 to 1 mg, because 0.25 mg feels like nothing after retatrutide and hunger comes back loud.
Never run both at once. Doubling up on GLP-1 drugs doubles the gut trouble, and nobody has shown it adds loss. If the appetite grip fades on either one after months, add a small weekly dose of cagrilintide rather than chasing the dose up. Alcohol sits badly on both, since a slowed stomach makes drinks hit harder; on retatrutide most people find it stops being worth it. Keep protein high and keep lifting the whole way down.
Side effects, side by side
Same incretin gut profile on both; retatrutide adds heat and runs harder near its top doses: